FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3009213018 | Bradykinin B2 inhibitor | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3520703016 | Substance with bradykinin B2 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3520875017 | Substance with bradykinin B2 inhibitor mechanism of action | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bradykinin B2 inhibitor | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Bradykinin B2 inhibitor | Is a | A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. | true | Inferred relationship | Some | ||
| Bradykinin B2 inhibitor | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Bradykinin B2 receptor antagonist (disposition) | true | Inferred relationship | Some | ||
| Bradykinin B2 inhibitor | Is a | Substance categorized by disposition | false | Inferred relationship | Some | ||
| Bradykinin B2 inhibitor | Is a | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Icatibant (substance) | Is a | True | Bradykinin B2 inhibitor | Inferred relationship | Some | |
| Product containing bradykinin B2 inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Bradykinin B2 inhibitor | Inferred relationship | Some | 1 |
| Icatibant acetate | Is a | True | Bradykinin B2 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets